BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 25714017)

  • 1. Molecular landscape of pancreatic cancer: implications for current clinical trials.
    Heestand GM; Kurzrock R
    Oncotarget; 2015 Mar; 6(7):4553-61. PubMed ID: 25714017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular landscape of prostate cancer: implications for current clinical trials.
    Khemlina G; Ikeda S; Kurzrock R
    Cancer Treat Rev; 2015 Nov; 41(9):761-6. PubMed ID: 26210103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of Assessing the Number of Mutated KRAS, CDKN2A, TP53, and SMAD4 Genes Using a Targeted Deep Sequencing Assay as a Prognostic Biomarker for Pancreatic Cancer.
    Hayashi H; Kohno T; Ueno H; Hiraoka N; Kondo S; Saito M; Shimada Y; Ichikawa H; Kato M; Shibata T; Morizane C; Sakamoto Y; Shimada K; Komatsu Y; Sakamoto N; Okusaka T
    Pancreas; 2017 Mar; 46(3):335-340. PubMed ID: 28099251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetics of Pancreatic Cancer and Its Implications on Therapy.
    Tatarian T; Winter JM
    Surg Clin North Am; 2016 Dec; 96(6):1207-1221. PubMed ID: 27865273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomics of gallbladder cancer: the case for biomarker-driven clinical trial design.
    Sicklick JK; Fanta PT; Shimabukuro K; Kurzrock R
    Cancer Metastasis Rev; 2016 Jun; 35(2):263-75. PubMed ID: 26857926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatic mutations in PIK3CA and activation of AKT in intraductal tubulopapillary neoplasms of the pancreas.
    Yamaguchi H; Kuboki Y; Hatori T; Yamamoto M; Shiratori K; Kawamura S; Kobayashi M; Shimizu M; Ban S; Koyama I; Higashi M; Shin N; Ishida K; Morikawa T; Motoi F; Unno M; Kanno A; Satoh K; Shimosegawa T; Orikasa H; Watanabe T; Nishimura K; Harada Y; Furukawa T
    Am J Surg Pathol; 2011 Dec; 35(12):1812-7. PubMed ID: 21945955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic analyses of isolated high-grade pancreatic intraepithelial neoplasia (HG-PanIN) reveal paucity of alterations in TP53 and SMAD4.
    Hosoda W; Chianchiano P; Griffin JF; Pittman ME; Brosens LA; Noë M; Yu J; Shindo K; Suenaga M; Rezaee N; Yonescu R; Ning Y; Albores-Saavedra J; Yoshizawa N; Harada K; Yoshizawa A; Hanada K; Yonehara S; Shimizu M; Uehara T; Samra JS; Gill AJ; Wolfgang CL; Goggins MG; Hruban RH; Wood LD
    J Pathol; 2017 May; 242(1):16-23. PubMed ID: 28188630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting KRAS for diagnosis, prognosis, and treatment of pancreatic cancer: Hopes and realities.
    Bournet B; Buscail C; Muscari F; Cordelier P; Buscail L
    Eur J Cancer; 2016 Feb; 54():75-83. PubMed ID: 26735353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome profiling of pancreatic adenocarcinoma.
    Birnbaum DJ; Adélaïde J; Mamessier E; Finetti P; Lagarde A; Monges G; Viret F; Gonçalvès A; Turrini O; Delpero JR; Iovanna J; Giovannini M; Birnbaum D; Chaffanet M
    Genes Chromosomes Cancer; 2011 Jun; 50(6):456-65. PubMed ID: 21412932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted next generation sequencing of endoscopic ultrasound acquired cytology from ampullary and pancreatic adenocarcinoma has the potential to aid patient stratification for optimal therapy selection.
    Gleeson FC; Kerr SE; Kipp BR; Voss JS; Minot DM; Tu ZJ; Henry MR; Graham RP; Vasmatzis G; Cheville JC; Lazaridis KN; Levy MJ
    Oncotarget; 2016 Aug; 7(34):54526-54536. PubMed ID: 27203738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Updates and Critical Evaluation on Novel Biomarkers for the Malignant Progression of Intraductal Papillary Mucinous Neoplasms of the Pancreas.
    Moris D; Damaskos C; Spartalis E; Papalampros A; Vernadakis S; Dimitroulis D; Griniatsos J; Felekouras E; Nikiteas N
    Anticancer Res; 2017 May; 37(5):2185-2194. PubMed ID: 28476781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From Genetic Alterations to Tumor Microenvironment: The Ariadne's String in Pancreatic Cancer.
    Bazzichetto C; Conciatori F; Luchini C; Simionato F; Santoro R; Vaccaro V; Corbo V; Falcone I; Ferretti G; Cognetti F; Melisi D; Scarpa A; Ciuffreda L; Milella M
    Cells; 2020 Jan; 9(2):. PubMed ID: 32012917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular biomarkers for progression of intraductal papillary mucinous neoplasm of the pancreas.
    Kuboki Y; Shimizu K; Hatori T; Yamamoto M; Shibata N; Shiratori K; Furukawa T
    Pancreas; 2015 Mar; 44(2):227-35. PubMed ID: 25423558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical implications of miRNAs in the pathogenesis, diagnosis and therapy of pancreatic cancer.
    Rachagani S; Macha MA; Heimann N; Seshacharyulu P; Haridas D; Chugh S; Batra SK
    Adv Drug Deliv Rev; 2015 Jan; 81():16-33. PubMed ID: 25453266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The discrete nature and distinguishing molecular features of pancreatic intraductal tubulopapillary neoplasms and intraductal papillary mucinous neoplasms of the gastric type, pyloric gland variant.
    Yamaguchi H; Kuboki Y; Hatori T; Yamamoto M; Shimizu K; Shiratori K; Shibata N; Shimizu M; Furukawa T
    J Pathol; 2013 Nov; 231(3):335-41. PubMed ID: 23893889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Utility of Circulating Tumor DNA for Molecular Assessment and Precision Medicine in Pancreatic Cancer.
    Takai E; Totoki Y; Nakamura H; Kato M; Shibata T; Yachida S
    Adv Exp Med Biol; 2016; 924():13-17. PubMed ID: 27753011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Past, Present, and Future of Pancreatic Cancer Clinical Trials.
    Matrisian LM; Berlin JD
    Am Soc Clin Oncol Educ Book; 2016; 35():e205-15. PubMed ID: 27249725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current and future therapies for advanced pancreatic cancer.
    Gupta R; Amanam I; Chung V
    J Surg Oncol; 2017 Jul; 116(1):25-34. PubMed ID: 28591939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Updated therapeutic outcome for patients with periampullary and pancreatic cancer related to recent translational research.
    Buanes TA
    World J Gastroenterol; 2016 Dec; 22(48):10502-10511. PubMed ID: 28082802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BRAF and FBXW7 (CDC4, FBW7, AGO, SEL10) mutations in distinct subsets of pancreatic cancer: potential therapeutic targets.
    Calhoun ES; Jones JB; Ashfaq R; Adsay V; Baker SJ; Valentine V; Hempen PM; Hilgers W; Yeo CJ; Hruban RH; Kern SE
    Am J Pathol; 2003 Oct; 163(4):1255-60. PubMed ID: 14507635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.